NRX Pharmaceuticals Form 4 Filing Shows Director Jonathan C Javitt Bought 100,000 Shares Of Stock At A Price Of $0.33/ Share
Portfolio Pulse from Happy Mohamed
Jonathan C Javitt, a director at NRX Pharmaceuticals, has purchased 100,000 shares of the company's stock at a price of $0.33 per share, according to a Form 4 filing with the SEC.
August 24, 2023 | 4:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Director Jonathan C Javitt's purchase of 100,000 shares of NRX Pharmaceuticals could indicate confidence in the company's future, potentially impacting the stock positively in the short term.
Insider trading, especially purchases, often signal the insiders' confidence in the company. In this case, Director Jonathan C Javitt's purchase of 100,000 shares could be seen as a positive sign by the market, potentially leading to an increase in the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100